• / Free eNewsletters & Magazine
  • / My Account
Home>Investor or Speculator?

Investor or Speculator?

Morningstar Articles

Tue, 12 Aug 2014

Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and

Related Videos

  1. Europe Growth: Gone for Good ?

    Facing entrenched structural issues, the eurozone's days of robust growth are likely over, but there are some reasons for hope, says Morningstar's Bob Johnson.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.